BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
4258
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Parent EE, Fowler AM. Nuclear Receptor Imaging In Vivo-Clinical and Research Advances. J Endocr Soc 2023;7:bvac197. [PMID: 36655003 DOI: 10.1210/jendso/bvac197] [Reference Citation Analysis]
2 Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma. J Transl Med 2022;20:602. [PMID: 36522647 DOI: 10.1186/s12967-022-03790-0] [Reference Citation Analysis]
3 Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases. Front Pharmacol 2022;13:991059. [DOI: 10.3389/fphar.2022.991059] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345